Literature DB >> 26439713

Alternative Splicing Signatures in RNA-seq Data: Percent Spliced in (PSI).

Sebastian Schafer1,2, Kui Miao3, Craig C Benson4, Matthias Heinig1,5,6, Stuart A Cook2,3,7, Norbert Hubner1,8,9.   

Abstract

Thousands of alternative exons are spliced out of messenger RNA to increase protein diversity. High-throughput sequencing of short cDNA fragments (RNA-seq) generates a genome-wide snapshot of these post-transcriptional processes. RNA-seq reads yield insights into the regulation of alternative splicing by revealing the usage of known or unknown splice sites as well as the expression level of exons. Constitutive exons are never covered by split alignments, whereas alternative exonic parts are located within highly expressed splicing junctions. The ratio between reads including or excluding exons, also known as percent spliced in index (PSI), indicates how efficiently sequences of interest are spliced into transcripts. This protocol describes a method to calculate the PSI without prior knowledge of splicing patterns. It provides a quantitative, global assessment of exon usage that can be integrated with other tools that identify differential isoform processing. Novel, complex splicing events along a genetic locus can be visualized in an exon-centric manner and compared across conditions.
Copyright © 2015 John Wiley & Sons, Inc.

Keywords:  PSI; RNA-seq; alternative splicing; isoform expression; percent spliced in; transcript processing

Mesh:

Year:  2015        PMID: 26439713     DOI: 10.1002/0471142905.hg1116s87

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  51 in total

1.  A Multiplexed Assay for Exon Recognition Reveals that an Unappreciated Fraction of Rare Genetic Variants Cause Large-Effect Splicing Disruptions.

Authors:  Rocky Cheung; Kimberly D Insigne; David Yao; Christina P Burghard; Jeffrey Wang; Yun-Hua E Hsiao; Eric M Jones; Daniel B Goodman; Xinshu Xiao; Sriram Kosuri
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

2.  Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes.

Authors:  Tyler Landrith; Bing Li; Ashley A Cass; Blair R Conner; Holly LaDuca; Danielle B McKenna; Kara N Maxwell; Susan Domchek; Nichole A Morman; Christopher Heinlen; Deborah Wham; Cathryn Koptiuch; Jennie Vagher; Ragene Rivera; Ann Bunnell; Gayle Patel; Jennifer L Geurts; Morgan M Depas; Shraddha Gaonkar; Sara Pirzadeh-Miller; Rebekah Krukenberg; Meredith Seidel; Robert Pilarski; Meagan Farmer; Khateriaa Pyrtel; Kara Milliron; John Lee; Elizabeth Hoodfar; Deepika Nathan; Amanda C Ganzak; Sitao Wu; Huy Vuong; Dong Xu; Aarani Arulmoli; Melissa Parra; Lily Hoang; Bhuvan Molparia; Michele Fennessy; Susanne Fox; Sinead Charpentier; Julia Burdette; Tina Pesaran; Jessica Profato; Brandon Smith; Ginger Haynes; Emily Dalton; Joy Rae-Radecki Crandall; Ruth Baxter; Hsiao-Mei Lu; Brigette Tippin-Davis; Aaron Elliott; Elizabeth Chao; Rachid Karam
Journal:  NPJ Precis Oncol       Date:  2020-02-24

3.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing.

Authors:  Beryl B Cummings; Jamie L Marshall; Taru Tukiainen; Monkol Lek; Sandra Donkervoort; A Reghan Foley; Veronique Bolduc; Leigh B Waddell; Sarah A Sandaradura; Gina L O'Grady; Elicia Estrella; Hemakumar M Reddy; Fengmei Zhao; Ben Weisburd; Konrad J Karczewski; Anne H O'Donnell-Luria; Daniel Birnbaum; Anna Sarkozy; Ying Hu; Hernan Gonorazky; Kristl Claeys; Himanshu Joshi; Adam Bournazos; Emily C Oates; Roula Ghaoui; Mark R Davis; Nigel G Laing; Ana Topf; Peter B Kang; Alan H Beggs; Kathryn N North; Volker Straub; James J Dowling; Francesco Muntoni; Nigel F Clarke; Sandra T Cooper; Carsten G Bönnemann; Daniel G MacArthur
Journal:  Sci Transl Med       Date:  2017-04-19       Impact factor: 17.956

4.  A synonymous VHL variant in exon 2 confers susceptibility to familial pheochromocytoma and von Hippel-Lindau disease.

Authors:  Shahida K Flores; Ziming Cheng; Angela M Jasper; Keiko Natori; Takahiro Okamoto; Akiyo Tanabe; Koro Gotoh; Hirotaka Shibata; Akihiro Sakurai; Takuya Nakai; Xiaojing Wang; Magnus Zethoven; Shiva Balachander; Yuichi Aita; William Young; Siyuan Zheng; Kazuhiro Takekoshi; Eijiro Nakamura; Richard W Tothill; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

5.  A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies.

Authors:  Véronique Bolduc; A Reghan Foley; Herimela Solomon-Degefa; Apurva Sarathy; Sandra Donkervoort; Ying Hu; Grace S Chen; Katherine Sizov; Matthew Nalls; Haiyan Zhou; Sara Aguti; Beryl B Cummings; Monkol Lek; Taru Tukiainen; Jamie L Marshall; Oded Regev; Dina Marek-Yagel; Anna Sarkozy; Russell J Butterfield; Cristina Jou; Cecilia Jimenez-Mallebrera; Yan Li; Corine Gartioux; Kamel Mamchaoui; Valérie Allamand; Francesca Gualandi; Alessandra Ferlini; Eric Hanssen; Steve D Wilton; Shireen R Lamandé; Daniel G MacArthur; Raimund Wagener; Francesco Muntoni; Carsten G Bönnemann
Journal:  JCI Insight       Date:  2019-03-21

6.  Global donor and acceptor splicing site kinetics in human cells.

Authors:  Leonhard Wachutka; Livia Caizzi; Julien Gagneur; Patrick Cramer
Journal:  Elife       Date:  2019-04-26       Impact factor: 8.140

7.  An alternative splicing signature model for predicting hepatocellular carcinoma-specific survival.

Authors:  Sheng Dong; Li-Jun Lu
Journal:  J Gastrointest Oncol       Date:  2020-10

8.  Extensive changes in gene expression and alternative splicing due to homoeologous exchange in rice segmental allopolyploids.

Authors:  Zhibin Zhang; Tiansi Fu; Zhijian Liu; Xutong Wang; Hongwei Xun; Guo Li; Baoxu Ding; Yuzhu Dong; Xiuyun Lin; Karen A Sanguinet; Bao Liu; Ying Wu; Lei Gong
Journal:  Theor Appl Genet       Date:  2019-05-16       Impact factor: 5.699

9.  Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos.

Authors:  Chuan Chen; Wenqiang Liu; Jiayin Guo; Yuanyuan Liu; Xuelian Liu; Jun Liu; Xiaoyang Dou; Rongrong Le; Yixin Huang; Chong Li; Lingyue Yang; Xiaochen Kou; Yanhong Zhao; You Wu; Jiayu Chen; Hong Wang; Bin Shen; Yawei Gao; Shaorong Gao
Journal:  Protein Cell       Date:  2021-04-22       Impact factor: 14.870

10.  Systematic Profiling of mRNA Splicing Reveals the Prognostic Predictor and Potential Therapeutic Target for Glioblastoma Multiforme.

Authors:  Botao Zhang; Quanyou Wu; Shujun Cheng; Wenbin Li
Journal:  J Oncol       Date:  2021-07-05       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.